Annual Interest Expense
$83.71 M
+$2.64 M+3.26%
December 31, 2022
Summary
- As of March 8, 2025, HZNP annual interest expense is $83.71 million, with the most recent change of +$2.64 million (+3.26%) on December 31, 2022.
- During the last 3 years, HZNP annual interest expense has fallen by -$3.38 million (-3.88%).
Performance
HZNP Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
$12.10 M
-$3.44 M-22.15%
June 30, 2023
Summary
- As of March 8, 2025, HZNP quarterly interest expense is $12.10 million, with the most recent change of -$3.44 million (-22.15%) on June 30, 2023.
- Over the past year, HZNP quarterly interest expense has dropped by -$9.31 million (-43.49%).
Performance
HZNP Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
$68.68 M
-$9.31 M-11.94%
June 30, 2023
Summary
- As of March 8, 2025, HZNP TTM interest expense is $68.68 million, with the most recent change of -$9.31 million (-11.94%) on June 30, 2023.
- Over the past year, HZNP TTM interest expense has dropped by -$19.01 million (-21.68%).
Performance
HZNP TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
HZNP Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | -43.5% | -21.7% |
| 3 y3 years | -3.9% | -34.9% | -6.5% |
| 5 y5 years | -33.8% | -61.0% | -21.1% |
HZNP Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -3.2% | -46.2% | at low | -22.7% | at low |
| 5 y | 5-year | -3.9% | -28.8% | -47.3% | -4.8% | -22.7% | -18.9% |
| alltime | all time | -33.8% | -99.0% | -62.2% | -97.6% | -45.7% | -99.1% |
Horizon Therapeutics Public Limited Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $12.10 M(-22.1%) | $68.68 M(-11.9%) |
| Mar 2023 | - | $15.54 M(-16.3%) | $77.99 M(-6.8%) |
| Dec 2022 | $83.71 M(+3.3%) | $18.56 M(-17.4%) | $83.71 M(-4.0%) |
| Sep 2022 | - | $22.48 M(+5.0%) | $87.19 M(-0.6%) |
| Jun 2022 | - | $21.41 M(+0.7%) | $87.69 M(-1.3%) |
| Mar 2022 | - | $21.26 M(-3.6%) | $88.86 M(+9.6%) |
| Dec 2021 | $81.06 M(+36.0%) | $22.05 M(-4.1%) | $81.06 M(+14.9%) |
| Sep 2021 | - | $22.98 M(+1.8%) | $70.53 M(+18.1%) |
| Jun 2021 | - | $22.58 M(+67.8%) | $59.74 M(+7.2%) |
| Mar 2021 | - | $13.46 M(+16.9%) | $55.73 M(-6.5%) |
| Dec 2020 | $59.62 M(-31.5%) | $11.52 M(-5.5%) | $59.62 M(-8.6%) |
| Sep 2020 | - | $12.19 M(-34.4%) | $65.20 M(-11.2%) |
| Jun 2020 | - | $18.57 M(+7.1%) | $73.44 M(-4.5%) |
| Mar 2020 | - | $17.34 M(+1.4%) | $76.90 M(-11.7%) |
| Dec 2019 | $87.09 M(-28.4%) | $17.10 M(-16.3%) | $87.09 M(-12.7%) |
| Sep 2019 | - | $20.43 M(-7.3%) | $99.76 M(-9.1%) |
| Jun 2019 | - | $22.03 M(-20.0%) | $109.77 M(-7.6%) |
| Mar 2019 | - | $27.53 M(-7.5%) | $118.77 M(-2.4%) |
| Dec 2018 | $121.69 M(-3.8%) | $29.77 M(-2.2%) | $121.69 M(-1.2%) |
| Sep 2018 | - | $30.44 M(-1.9%) | $123.15 M(-1.0%) |
| Jun 2018 | - | $31.03 M(+1.9%) | $124.42 M(-0.5%) |
| Mar 2018 | - | $30.45 M(-2.5%) | $124.99 M(-1.2%) |
| Dec 2017 | $126.52 M(+46.1%) | $31.23 M(-1.5%) | $126.52 M(+1.9%) |
| Sep 2017 | - | $31.71 M(+0.3%) | $124.16 M(+11.3%) |
| Jun 2017 | - | $31.61 M(-1.2%) | $111.52 M(+12.5%) |
| Mar 2017 | - | $31.98 M(+10.8%) | $99.14 M(+14.5%) |
| Dec 2016 | $86.61 M | $28.86 M(+51.4%) | $86.61 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $19.07 M(-0.8%) | $77.87 M(-1.6%) |
| Jun 2016 | - | $19.23 M(-1.2%) | $79.11 M(-0.3%) |
| Mar 2016 | - | $19.46 M(-3.3%) | $79.33 M(+13.5%) |
| Dec 2015 | $69.90 M(+193.4%) | $20.12 M(-0.9%) | $69.90 M(+16.5%) |
| Sep 2015 | - | $20.30 M(+4.4%) | $60.00 M(+33.6%) |
| Jun 2015 | - | $19.45 M(+93.9%) | $44.89 M(+51.4%) |
| Mar 2015 | - | $10.03 M(-1.8%) | $29.65 M(+24.4%) |
| Dec 2014 | $23.83 M(+86.5%) | $10.22 M(+96.7%) | $23.83 M(+51.4%) |
| Sep 2014 | - | $5.19 M(+23.5%) | $15.74 M(+11.3%) |
| Jun 2014 | - | $4.21 M(0.0%) | $14.14 M(+5.7%) |
| Mar 2014 | - | $4.21 M(+97.7%) | $13.38 M(+4.7%) |
| Dec 2013 | $12.77 M(+10.6%) | $2.13 M(-40.9%) | $12.77 M(+14.9%) |
| Sep 2013 | - | $3.60 M(+4.6%) | $11.12 M(+2.4%) |
| Jun 2013 | - | $3.44 M(-4.5%) | $10.86 M(+2.4%) |
| Mar 2013 | - | $3.60 M(+665.0%) | $10.60 M(-8.2%) |
| Dec 2012 | $11.55 M(+83.8%) | $471.00 K(-85.9%) | $11.55 M(+4.3%) |
| Sep 2012 | - | $3.34 M(+4.6%) | $11.08 M(+43.1%) |
| Jun 2012 | - | $3.19 M(-29.9%) | $7.74 M(+70.1%) |
| Mar 2012 | - | $4.55 M(+254.2%) | $4.55 M(+151.7%) |
| Dec 2011 | $6.28 M(+107.8%) | - | - |
| Mar 2011 | - | $1.28 M(+145.7%) | $1.81 M(+28.5%) |
| Dec 2010 | $3.02 M(+248.0%) | - | - |
| Jun 2010 | - | $523.00 K(+83.5%) | $1.41 M(+5.3%) |
| Mar 2010 | - | $285.00 K(-52.4%) | $1.34 M(-18.9%) |
| Sep 2009 | - | $599.00 K(+32.5%) | $1.65 M(+57.2%) |
| Jun 2009 | - | $452.00 K(-24.2%) | $1.05 M(+75.8%) |
| Mar 2009 | - | $596.00 K | $596.00 K |
| Dec 2008 | $869.00 K | - | - |
FAQ
- What is Horizon Therapeutics Public Limited annual interest expense?
- What is the all time high annual interest expense for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual interest expense year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly interest expense?
- What is the all time high quarterly interest expense for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly interest expense year-on-year change?
- What is Horizon Therapeutics Public Limited TTM interest expense?
- What is the all time high TTM interest expense for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM interest expense year-on-year change?
What is Horizon Therapeutics Public Limited annual interest expense?
The current annual interest expense of HZNP is $83.71 M
What is the all time high annual interest expense for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual interest expense is $126.52 M
What is Horizon Therapeutics Public Limited annual interest expense year-on-year change?
Over the past year, HZNP annual interest expense has changed by +$2.64 M (+3.26%)
What is Horizon Therapeutics Public Limited quarterly interest expense?
The current quarterly interest expense of HZNP is $12.10 M
What is the all time high quarterly interest expense for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly interest expense is $31.98 M
What is Horizon Therapeutics Public Limited quarterly interest expense year-on-year change?
Over the past year, HZNP quarterly interest expense has changed by -$9.31 M (-43.49%)
What is Horizon Therapeutics Public Limited TTM interest expense?
The current TTM interest expense of HZNP is $68.68 M
What is the all time high TTM interest expense for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM interest expense is $126.52 M
What is Horizon Therapeutics Public Limited TTM interest expense year-on-year change?
Over the past year, HZNP TTM interest expense has changed by -$19.01 M (-21.68%)